| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $12.7M | -13.3% |
| SG&A Expense | $10.4M | -1.6% |
| Operating Income | -$23.1M | +8.4% |
| Net Income | -$30.0M | +6.6% |
| EPS (Basic) | -$4.61 | +23.3% |
| EPS (Diluted) | -$4.61 | +23.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $40.9M | +13.4% |
| Current Assets | $42.0M | +4.6% |
| Total Assets | $56.9M | +3.3% |
| Current Liabilities | $3.3M | +142.5% |
| Total Liabilities | $85.4M | +13.6% |
| Stockholders' Equity | -$28.5M | -42.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.8M | +40.0% |
| Capital Expenditures | $16K | +0.0% |
| Investing Cash Flow | -$16K | +0.0% |
| Financing Cash Flow | $19.6M | — |
| Free Cash Flow | -$14.8M | +40.0% |